NLRP3 and hyperlipidemia: In our study, we also found that tBHQ attenuated hyperlipidemia-induced renal injury, and the potential protective mechanism of tBHQ involved inhibiting mtROS–NLRP3 inflammasome activation via the upregulation of Nrf2/ARE-related antioxidant signaling.